Evaluation of TP US in Women With Prolapse
Sponsor
Aljazeera Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03820089
Collaborator
Cairo University (Other)
100
1
11.9
8.4
Study Details
Study Description
Brief Summary
Many women suffers from uterine and vaginal prolapse Usually they suffer from these symotoms in menopause
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The most common cause of pelvic organ prolapse is multiple pregnancy and multiparity
Study Design
Study Type:
Observational [Patient Registry]
Actual Enrollment
:
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of TP US Assesment of Women With Prolapse
Actual Study Start Date
:
Jan 29, 2019
Actual Primary Completion Date
:
Jan 20, 2020
Actual Study Completion Date
:
Jan 25, 2020
Outcome Measures
Primary Outcome Measures
- The number of women who will be properly diagnosed with prolapse by TP us [within 2 months]
The accuracy of TP US in diagnosing the prolapse
Eligibility Criteria
Criteria
Ages Eligible for Study:
25 Years
to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Women with history of normal delivery Age between 25 to 75 years
Exclusion Criteria:
- women with cesarean deliveries
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Algazeerah and Kasralainy hospital | Giza | Egypt |
Sponsors and Collaborators
- Aljazeera Hospital
- Cairo University
Investigators
- Principal Investigator: Mahmoud Alalfy, PhD, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Aljazeera Hospital
ClinicalTrials.gov Identifier:
NCT03820089
Other Study ID Numbers:
- prolapse
First Posted:
Jan 29, 2019
Last Update Posted:
Feb 10, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: